M
Magne Kongshaug
Researcher at University of Oslo
Publications - 23
Citations - 2224
Magne Kongshaug is an academic researcher from University of Oslo. The author has contributed to research in topics: Hematoporphyrin & Photodynamic therapy. The author has an hindex of 12, co-authored 23 publications receiving 2162 citations.
Papers
More filters
Journal ArticleDOI
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Qian Peng,Trond Warloe,Kristian Berg,Johan Emelian Moan,Magne Kongshaug,Karl Erik Giercksky,Jahn M. Nesland +6 more
TL;DR: Studies have shown that a higher accumulation of ALA‐derived PpIX in rapidly proliferating cells may provide a biologic rationale for clinical use of ALa‐based PDT and diagnosis, however, no review updating the clinical data has appeared so far.
Journal ArticleDOI
5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research
TL;DR: Because PpIX is an efficient photosensitizer, ALA has been introduced as a drug for clinical photodynamic therapy (PDT) of cancer (8,9).
Journal Article
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Trond Warloe,Jahn M. Nesland,Karl Erik Giercksky,Magne Kongshaug,Qian Peng,Johan Emelian Moan,Timo K. van den Berg +6 more
Journal ArticleDOI
Interaction of cremophor el with human plasma
TL;DR: Interaction of cremophor EL (CRM) with human plasma lipoproteins and nonlipoins has been investigated by ultracentrifugation and a destruction of HDL can be observed.